Marksans Pharma acquires Hale Group

The board of Marksans Pharma has decided to enter into share purchase agreement with Hale Group, U.K. for acquiring its entire share capital along with its subsidiary company Bell, Sons & Co. (Druggists) and authority to Mark Saldanha, managing director to execute the same. The above acquisition shall be through companies 100% subsidiary, Marksans Pharma U.K.